Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results—Do We Have the Proper Device?

Table 1

Clinical and procedural data of elderly patients aged >55 years old, in whom PDA was closed percutaneously.

No.	Age (y)	Weight (kg)	NYHA class before	PDA type	Calcifications (0/1)	Narrowest PDA diameter (mm)	PDA length (mm)	Implant type	Implant size (mm)	Implantation route (v/a)	Complications/others	Fluoroscopy time (min)	Procedure time (min)	Residual shunt in echocardiography after 24 hours/one year	NYHA class after one year
1	62	90	1	A	0	6	8	DO I	8/10	v	Nitroglycerine infusion	14	60	None	No symptoms
2	62	64	—	B	1	5	5	StarFlex	23	v		28	135	None	No symptoms
3	58	62	2	C	0	4	4	DO I	6/8	v		16	90	None	1
4	56	60	2	A	0	5.7	24	DO I	10/12	v	Groin haematoma	11	55	None	—
5	56	84	3	A	1	7	8	VSO	12	v	Groin haematoma	14	145	None	1
6	56	68	3	Postsurgery	1	5	20	DO I	8/10	v		15	58	None	1
7	75	77	2	B	1	6	3	StarFlex	23	v		29	95	None	—
8	85	50	3	A	1	3.2	16	DO I	8/10	v		12	90	None	—
9	65	85	2	A	0	6.7	12	DO I	10/12	v		23	80	None	1
10	58	78	3	C	0	5.2	—	DO I	8/10	v	Groin haematoma, nitroglycerine infusion	13	50	None	—
11	63	48	2	A	1	5.5	—	VSO	8	v	AF cardioversion	6	45	None	1
12	73	56	3	A	1	4	7	DO I	8/10	v		11	50	None	1
13	72	50	3	B	1	6	4	ASO	8	v		28	100	None	—
14	58	82	2	A	1	4	—	DO I	8/10	v		6	70	None	1
15	59	64	2	A	0	4.9	12	DO I	10/12	v	8/10 unstable	15	60	None	1
16	56	63	2	A	1	4.2	10	DO I	10/12	v		22	75	None	1
17	58	45	3	A	0	5	—	DO I	8/10	v		10	50	None	1
18	57	81	2	A	0	3.5	9	DO I	8/10	v		4	45	None	1
19	76	70	3	C	1	3.5	—	DO I	8/10	v		8	43	None	1
20	64	76	3	A	1	3.8	—	DO I	10/12	v	Groin haematoma	21	60	None	1
21	64	57	3	C	1	4	7	VSO	10	a		31	80	Small/small	1
22	59	80	2	E	0	1.5	9	ADO II AS	6 × 6	a	ADO II AS embolisation to pulmonary artery, percutaneous removal; ADO II 6 × 6 mm implanted successfully	9	48	None	2
23	74	71	2	A	1	4	—	DO I	10/12	v		6	45	None	1
24	69	64	1	D	0	3	15	AVP II	10	v		4	50	None	No symptoms
25	74	66	1	A	0	4	14	DO I	10/12	v	Groin haematoma	10	75	None	No symptoms
26	56	60	—	A	0	3	—	ADO II	4 × 4	a		4	14	None	No symptoms
27	70	70	1	A	0	3.2	10	ADO II	6 × 4	v		4	45	None	No symptoms
28	56	55	—	A	0	2.5	7.5	ADO II AS	5 × 6	a		3	15	None	No symptoms
29	77	74	2	A	1	5	6	ADO II	6 × 4	a	Nitroglycerine infusion	9	90	Small/none	1
30	60	66	2	C	0	3.5	7	ADO II	5 × 6	a		6	50	None	2
31	66	92	3	A	1	7	5	AVP II	10	a		4	40	None	1
32	64	80	1	D	0	5	12	ADO II	3 × 4	a		7	65	None	No symptoms
33	72	55	2	A	1	5	9	ADO II	5 × 4	a		4	35	None	1

ADO II, Amplatzer duct occluder type II; ADO II AS, Amplatzer duct occluder type II additional sizes; ASO, Amplatzer atrial septal occluder; AVP II, Amplatzer vascular plug type II a, arterial; AF, atrial fibrillation; DO I, duct occluder type I; f, female; m, male; MR, mitral regurgitation; VSO, Amplatzer muscular VSD occluder; v, venous; y, years; —, no data.